Tag Archives: adults

Danish TV show that pairs kids and naked adults slammed as depraved

On one TV show, the truth is actually naked. In Denmark, an award-winning television program called “Ultra Strips Down,” puts nude adults in front of school-age children. The series allows its young participants, ages 11 to 13, to ask the grown-up volunteers whatever questions are on their minds in order to promote body positivity and… Read More »

FDA Approves Merck’s Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)

Print this page KENILWORTH, N.J.–(BUSINESS WIRE) June 5, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Recarbrio™ (imipenem, cilastatin, and relebactam) for the treatment of patients 18 years of age… Read More »

Older adults who drink tea are less likely to be depressed

Previous research has suggested that there is a link between depression and tea drinking. Now, a new study is investigating this relationship further. Depression is common among older adults, with 7% of those over the age of 60 years reporting “major depressive disorder.” Accordingly, research is underway to identify possible causes, which include genetic predisposition,… Read More »

FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia

FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia Print this page Miami, FL And Jersey City, NJ, October 15, 2019 — Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved Secuado (asenapine) transdermal system, the first-and-only transdermal patch… Read More »

FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease

FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease Print this page TOKYO–(BUSINESS WIRE)– August 28, 2019 — Kyowa Kirin Co., Ltd., (Kyowa Kirin, TYO: 4151) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Nourianz (istradefylline) for use as adjunctive treatment… Read More »